This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wahl, F. Articles by Boulu, R. G. Search for Related Content PubMed PubMed Citation Articles by Wahl, F. Articles by Boulu, R. G.

Stroke, Vol 23, 267-272, Copyright © 1992 by American Heart Association

ARTICLES

Neurological and behavioral outcomes of focal cerebral ischemia in rats

F Wahl, M Allix, M Plotkine and RG Boulu
Faculte des Sciences Pharmaceutiques et Biologiques, Universite Rene Descartes, Paris, France.

BACKGROUND AND PURPOSE: The aim of this study was to investigate the neurobehavioral consequences of focal ischemia in rats. METHODS: We induced permanent occlusion of the left middle cerebral artery in 14 Sprague-Dawley rats, and used 13 sham-operated rats as controls. During surgery, brain temperature and body temperature were kept at normothermia. Neurobehavioral studies (neurological examination, passive avoidance task, Y maze test, and modified open-field test) were carried out 4 days after ischemia before killing the rats to evaluate histological damage. RESULTS: Ischemia induced large infarcts in the cortex (138.6 +/- 8.5 mm3) and caudate-putamen (48.8 +/- 2.6 mm3) and, compared with sham-operated rats, produced a dramatic neurological deficit (p less than 0.001) characterized by sensorimotor dysfunctions and hemiplegia. Memory retention was significantly (p less than 0.05) impaired in the passive avoidance task, but neither vigilance and exploratory behavior measured in the modified open-field test nor working memory evaluated in the Y maze test were disturbed. Infarct size was not correlated with the neurological or behavioral deficits. CONCLUSIONS: This lack of correlation indicates the necessity of carrying out parallel histological, neurological, and behavioral studies in any assays of new drugs using this model of focal ischemia.

This article has been cited by other articles:

				W. Kozak, A. Kozak, M. H. Johnson, H. F. Elewa, and S. C. Fagan Vascular Protection with Candesartan after Experimental Acute Stroke in Hypertensive Rats: A Dose-Response Study J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 773 - 782. [Abstract] [Full Text] [PDF]

				C. Kleinschnitz, M. Pozgajova, M. Pham, M. Bendszus, B. Nieswandt, and G. Stoll Targeting Platelets in Acute Experimental Stroke: Impact of Glycoprotein Ib, VI, and IIb/IIIa Blockade on Infarct Size, Functional Outcome, and Intracranial Bleeding Circulation, May 1, 2007; 115(17): 2323 - 2330. [Abstract] [Full Text] [PDF]

				B. Winter, B. Bert, H. Fink, U. Dirnagl, and M. Endres Dysexecutive Syndrome After Mild Cerebral Ischemia?: Mice Learn Normally but Have Deficits in Strategy Switching Stroke, January 1, 2004; 35(1): 191 - 195. [Abstract] [Full Text] [PDF]

				L. Belayev, L. Khoutorova, T. A. Deisher, A. Belayev, R. Busto, Y. Zhang, W. Zhao, and M. D. Ginsberg Neuroprotective Effect of SolCD39, a Novel Platelet Aggregation Inhibitor, on Transient Middle Cerebral Artery Occlusion in Rats Stroke, March 1, 2003; 34(3): 758 - 763. [Abstract] [Full Text] [PDF]

				R. L. Roof, G. P. Schielke, X. Ren, and E. D. Hall A Comparison of Long-Term Functional Outcome After 2 Middle Cerebral Artery Occlusion Models in Rats Stroke, November 1, 2001; 32(11): 2648 - 2657. [Abstract] [Full Text] [PDF]

				V. Mary, F. Wahl, A. Uzan, and J.-M. Stutzmann Enoxaparin in Experimental Stroke : Neuroprotection and Therapeutic Window of Opportunity Stroke, April 1, 2001; 32(4): 993 - 999. [Abstract] [Full Text] [PDF]

				K. Hattori, H. Lee, P. D. Hurn, B. J. Crain, R. J. Traystman, A. C. DeVries, and B. G. Lyeth Cognitive Deficits After Focal Cerebral Ischemia in Mice Editorial Comment Stroke, August 1, 2000; 31(8): 1939 - 1944. [Abstract] [Full Text] [PDF]

				P.-E. Chabrier, M. Auguet, B. Spinnewyn, S. Auvin, S. Cornet, C. Demerle-Pallardy, C. Guilmard-Favre, J.-G. Marin, B. Pignol, V. Gillard-Roubert, et al. BN 80933, a dual inhibitor of neuronal nitric oxide synthase and lipid peroxidation: A promising neuroprotective strategy PNAS, September 14, 1999; 96(19): 10824 - 10829. [Abstract] [Full Text] [PDF]

				D. C. Rogers, C. A. Campbell, J. L. Stretton, and K. B. Mackay Correlation Between Motor Impairment and Infarct Volume After Permanent and Transient Middle Cerebral Artery Occlusion in the Rat Stroke, October 1, 1997; 28(10): 2060 - 2066. [Abstract] [Full Text]

				L. Belayev, O. F. Alonso, R. Busto, W. Zhao, M. D. Ginsberg, and C. Y. Hsu Middle Cerebral Artery Occlusion in the Rat by Intraluminal Suture: Neurological and Pathological Evaluation of an Improved Model Stroke, September 1, 1996; 27(9): 1616 - 1623. [Abstract] [Full Text]

				L. Belayev, R. Busto, W. Zhao, and M. D. Ginsberg HU-211, a Novel Noncompetitive N-Methyl-D-Aspartate Antagonist, Improves Neurological Deficit and Reduces Infarct Volume After Reversible Focal Cerebral Ischemia in the Rat Stroke, December 1, 1995; 26(12): 2313 - 2320. [Abstract] [Full Text]

				N. Takagi, H. Tsuru, M. Yamamura, and S. Takeo Changes in Striatal Dopamine Metabolism After Microsphere Embolism in Rats Stroke, June 1, 1995; 26(6): 1101 - 1106. [Abstract] [Full Text]

				J. H. Garcia, S. Wagner, K.-F. Liu, and X.-j. Hu Neurological Deficit and Extent of Neuronal Necrosis Attributable to Middle Cerebral Artery Occlusion in Rats : Statistical Validation Stroke, April 1, 1995; 26(4): 627 - 635. [Abstract] [Full Text]